N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole

C67H71ClN18O4 — CID 158113292

IUPACN-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole
SMILESCC(C)(C)OC(=O)NCc1ccc(N)cc1.Cc1nc2ccccc2n1-c1cncc(Cl)n1.Cc1nc2ccccc2n1-c1cncc(Nc2ccc(CN)cc2)n1.Cc1nc2ccccc2n1-c1cncc(Nc2ccc(CNC(=O)OC(C)(C)C)cc2)n1
InChIInChI=1S/C24H26N6O2.C19H18N6.C12H9ClN4.C12H18N2O2/c1-16-27-19-7-5-6-8-20(19)30(16)22-15-25-14-21(29-22)28-18-11-9-17(10-12-18)13-26-23(31)32-24(2,3)4;1-13-22-16-4-2-3-5-17(16)25(13)19-12-21-11-18(24-19)23-15-8-6-14(10-20)7-9-15;1-8-15-9-4-2-3-5-10(9)17(8)12-7-14-6-11(13)16-12;1-12(2,3)16-11(15)14-8-9-4-6-10(13)7-5-9/h5-12,14-15H,13H2,1-4H3,(H,26,31)(H,28,29);2-9,11-12H,10,20H2,1H3,(H,23,24);2-7H,1H3;4-7H,8,13H2,1-3H3,(H,14,15)
InChIKeyFQRSMLRUYWFBSX-UHFFFAOYSA-N
MW1227.88 g/mol
LogP13.29
Rot. Bonds12

About N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole

N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole (PubChem CID 158113292) has the molecular formula C67H71ClN18O4 and a molecular weight of 1227.88 g/mol. Its IUPAC name is N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole.

Molecular Properties

Compound NameN-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole
PubChem CID158113292
Molecular FormulaC67H71ClN18O4
Molecular Weight1227.88 g/mol
Exact Mass1226.56
IUPAC NameN-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole
SMILESCC(C)(C)OC(=O)NCc1ccc(N)cc1.Cc1nc2ccccc2n1-c1cncc(Cl)n1.Cc1nc2ccccc2n1-c1cncc(Nc2ccc(CN)cc2)n1.Cc1nc2ccccc2n1-c1cncc(Nc2ccc(CNC(=O)OC(C)(C)C)cc2)n1
InChIInChI=1S/C24H26N6O2.C19H18N6.C12H9ClN4.C12H18N2O2/c1-16-27-19-7-5-6-8-20(19)30(16)22-15-25-14-21(29-22)28-18-11-9-17(10-12-18)13-26-23(31)32-24(2,3)4;1-13-22-16-4-2-3-5-17(16)25(13)19-12-21-11-18(24-19)23-15-8-6-14(10-20)7-9-15;1-8-15-9-4-2-3-5-10(9)17(8)12-7-14-6-11(13)16-12;1-12(2,3)16-11(15)14-8-9-4-6-10(13)7-5-9/h5-12,14-15H,13H2,1-4H3,(H,26,31)(H,28,29);2-9,11-12H,10,20H2,1H3,(H,23,24);2-7H,1H3;4-7H,8,13H2,1-3H3,(H,14,15)
InChIKeyFQRSMLRUYWFBSX-UHFFFAOYSA-N
XLogP13.29
TPSA283.56 Ų
H-Bond Donors6
H-Bond Acceptors20
Rotatable Bonds12
Heavy Atoms90
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001227.88
LogP ≤ 513.29
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_no_alk(40)', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole?
The IUPAC name of N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole (CID 158113292) is N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole.
What is the SMILES notation for N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole?
The canonical SMILES for N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole is CC(C)(C)OC(=O)NCc1ccc(N)cc1.Cc1nc2ccccc2n1-c1cncc(Cl)n1.Cc1nc2ccccc2n1-c1cncc(Nc2ccc(CN)cc2)n1.Cc1nc2ccccc2n1-c1cncc(Nc2ccc(CNC(=O)OC(C)(C)C)cc2)n1.
What is the InChIKey of N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole?
The InChIKey is FQRSMLRUYWFBSX-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H26N6O2.C19H18N6.C12H9ClN4.C12H18N2O2/c1-16-27-19-7-5-6-8-20(19)30(16)22-15-25-14-21(29-22)28-18-11-9-17(10-12-18)13-26-23(31)32-24(2,3)4;1-13-22-16-4-2-3-5-17(16)25(13)19-12-21-11-18(24-19)23-15-8-6-14(10-20)7-9-15;1-8-15-9-4-2-3-5-10(9)17(8)12-7-14-6-11(13)16-12;1-12(2,3)16-11(15)14-8-9-4-6-10(13)7-5-9/h5-12,14-15H,13H2,1-4H3,(H,26,31)(H,28,29);2-9,11-12H,10,20H2,1H3,(H,23,24);2-7H,1H3;4-7H,8,13H2,1-3H3,(H,14,15).
What are the key properties of N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole?
N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole has a molecular weight of 1227.88 g/mol, XLogP of 13.29, 12 rotatable bonds, 6 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(aminomethyl)phenyl]-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;tert-butyl N-[(4-aminophenyl)methyl]carbamate;tert-butyl N-[[4-[[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]amino]phenyl]methyl]carbamate;1-(6-chloropyrazin-2-yl)-2-methylbenzimidazole is sourced from PubChem (CID 158113292), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).